(Q46344166)

21 December 2017

title

Immunosuppressive regulatory T cells are associated with aggressive breast cancer phenotypes: a potential therapeutic target (English)

1 reference

21 December 2017

author name string

Sandra D Bohling

series ordinal

1

1 reference

21 December 2017

Kimberly H Allison

series ordinal

2

1 reference

21 December 2017

publication date

26 September 2008

1 reference

21 December 2017

published in

Modern Pathology

1 reference

21 December 2017

volume

21

1 reference

21 December 2017

issue

12

1 reference

21 December 2017

page(s)

1527-1532

1 reference

21 December 2017

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.160

7 January 2021

Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.160

7 January 2021

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.160

1 reference

7 January 2021

Coordination of early protective immunity to viral infection by regulatory T cells

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.160

7 January 2021

Control of regulatory T cell development by the transcription factor Foxp3

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.160

7 January 2021

Regulating regulatory T cells

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.160

7 January 2021

A shift in the phenotype of melan-A-specific CTL identifies melanoma patients with an active tumor-specific immune response

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.160

7 January 2021

Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.160

7 January 2021

Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.160

7 January 2021

Mature dendritic cells prime functionally superior melan-A-specific CD8+ lymphocytes as compared with nonprofessional APC.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.160

7 January 2021

Blockade of B7-H1 improves myeloid dendritic cell–mediated antitumor immunity

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.160

7 January 2021

Regulatory T cells under scrutiny

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.160

7 January 2021

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.160

7 January 2021

Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.160

7 January 2021

Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.160

7 January 2021

Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory T cells.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.160

7 January 2021

CD4(+) regulatory T cells

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.160

7 January 2021

CD4+ CD25+ suppressor T cells: more questions than answers

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.160

7 January 2021

Antigen-induced regulatory T cells in autoimmunity

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.160

7 January 2021

Regulatory T cells in transplantation tolerance

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.160

7 January 2021

Quantification of Regulatory T Cells Enables the Identification of High-Risk Breast Cancer Patients and Those at Risk of Late Relapse

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.160

7 January 2021

Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.160

7 January 2021

FOXP3+ Tregs and B7-H1+/PD-1+ T lymphocytes co-infiltrate the tumor tissues of high-risk breast cancer patients: Implication for immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.160

7 January 2021

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.160

7 January 2021

FOXP3 immunohistochemistry on formalin-fixed paraffin-embedded tissue: poor correlation between different antibodies.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.160

7 January 2021

Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.160

7 January 2021

Tumor necrosis is a prognostic predictor for early recurrence and death in lymph node-positive breast cancer: a 10-year follow-up study of 728 Eastern Cooperative Oncology Group patients

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.160

7 January 2021

Long-term survival of patients with breast cancer: a study of the curability of the disease

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.160

7 January 2021

Factors predicting late mortality from breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.160

7 January 2021

Pathologic Complete Response to Neoadjuvant Chemotherapy of Breast Carcinoma Is Associated with the Disappearance of Tumor-Infiltrating Foxp3+ Regulatory T Cells

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.160

7 January 2021

Localisation pattern of Foxp3+ regulatory T cells is associated with clinical behaviour in gastric cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.160

7 January 2021

Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.160

7 January 2021

Depletion of CD4+ CD25+ regulatory cells augments the generation of specific immune T cells in tumor-draining lymph nodes

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.160

7 January 2021

IL-2 immunotoxin therapy modulates tumor-associated regulatory T cells and leads to lasting immune-mediated rejection of breast cancers in neu-transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.160

7 January 2021

DAB(389)IL-2 (ONTAK): a novel fusion toxin therapy for lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.160

7 January 2021

Tregs and rethinking cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.160

7 January 2021

Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.160

7 January 2021

10.1038/MODPATHOL.2008.160

Identifiers

DOI

1 reference

21 December 2017

1 reference

21 December 2017